Loading...
PhD Maša Omerzel

PhD Maša Omerzel
no.: 34373 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
569.74
A''
43.81
A'
345.19
A1/2
431.73
CI10
484
CImax
41
h10
13
A1
2.07
A3
4.61
Data for the last 5 years (citations for the last 10 years) on June 13, 2024; A3 for period 2018-2022 (update for tender in 2023: YES)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 63  709  374  5.94 
Scopus 64  853  487  7.61 
Mentoring junior researchers
source: ARIS
no. Name and surname Type Period Code
1 PhD Tilen Komel  Bologna doctoral studies  10/1/2019 - 9/30/2023  53504 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (100%, RD:100%)  Institute of Oncology Ljubljana  Department of research 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J3-50108  DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers   2023 - 2024  PhD Katarina Žnidar  2,208 
2. J4-50150  Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy   2023 - 2024  PhD Nina Kostevšek  3,930 
3. L3-50111  Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL   2023 - 2024  PhD Maja Čemažar  2,849 
4. J3-50110  Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept   2023 - 2024  PhD Katja Uršič Valentinuzzi  3,112 
5. J1-4417  Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy   2022 - 2024  PhD Matej Sova  3,954 
6. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,100 
7. L7-4491  Development of integrated multi-channel artificial nose for detection of cancer   2022 - 2023  PhD Igor Muševič  5,502 
8. J3-4504  Uncovering the glioblastoma microenvironment to enhance the therapy   2022 - 2023  PhD Metka Novak  1,794 
9. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   2022 - 2023  PhD Gregor Serša  6,811 
10. Z3-1871  Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer   2019 - 2021  PhD Maša Omerzel  200 
11. L2-7550  Elecrospun nanofibrous materials for solid state drug delivery system   2016  PhD Igor Emri  4,449 
12. J3-7494  Tunneling nanotubes for innovative urinary bladder cancer treatments   2016  PhD Mateja Erdani Kreft  7,121 
13. J1-6730  Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection   2015 - 2016  PhD Metka Filipič  4,071 
14. J3-6796  Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin   2015 - 2016  PhD Maja Čemažar  4,772 
15. J3-6793  New approaches of tumor radiosenzibilization with gene therapy   2014 - 2016  PhD Gregor Serša  5,119 
16. J3-5505  Electrochemotherapy in treatment of deep seated tumors   2013 - 2016  PhD Gregor Serša  4,292 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P3-0003  Development and evaluation of new approaches to cancer treatment   2022 - 2024  PhD Gregor Serša  3,971 
2. P3-0003  Development and evaluation of new approaches to cancer treatment   2015 - 2021  PhD Gregor Serša  3,283 
3. P3-0003  Development and evaluation of new approaches to cancer treatment   2011 - 2014  PhD Gregor Serša  4,042 
We were not given permission by the researcher to publish data.
Views history
Favourite